Non-Aspergillus Hyaline Molds: A Host-Based Perspective of Emerging Pathogenic Fungi Causing Sinopulmonary Diseases

The incidence of invasive sino-pulmonary diseases due to non-Aspergillus hyaline molds is increasing due to an enlarging and evolving population of immunosuppressed hosts as well as improvements in the capabilities of molecular-based diagnostics. Herein, we review the following opportunistic pathogens known to cause sinopulmonary disease, the most common manifestation of hyalohyphomycosis: Fusarium spp., Scedosporium spp., Lomentospora prolificans, Scopulariopsis spp., Trichoderma spp., Acremonium spp., Paecilomyces variotii, Purpureocillium lilacinum, Rasamsonia argillacea species complex, Arthrographis kalrae, and Penicillium species. To facilitate an understanding of the epidemiology and clinical features of sino-pulmonary hyalohyphomycoses in the context of host immune impairment, we utilized a host-based approach encompassing the following underlying conditions: neutropenia, hematologic malignancy, hematopoietic and solid organ transplantation, chronic granulomatous disease, acquired immunodeficiency syndrome, cystic fibrosis, and healthy individuals who sustain burns, trauma, or iatrogenic exposures. We further summarize the pre-clinical and clinical data informing antifungal management for each pathogen and consider the role of adjunctive surgery and/or immunomodulatory treatments to optimize patient outcome.

[1]  B. Moriyama,et al.  Osteoarticular Mycoses , 2022, Clinical microbiology reviews.

[2]  D. Kontoyiannis,et al.  Checkpoint inhibitors as immunotherapy for fungal infections: Promises, challenges, and unanswered questions , 2022, Frontiers in Immunology.

[3]  B. Patel,et al.  Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (rhu GM-CSF) as Adjuvant Therapy for Invasive Fungal Diseases , 2022, Open forum infectious diseases.

[4]  D. Seidel,et al.  Invasive Trichoderma spp. infections: clinical presentation and outcome of cases from the literature and the FungiScope® registry , 2022, The Journal of antimicrobial chemotherapy.

[5]  S. Ormanns,et al.  Nivolumab induces long-term remission in a patient with fusariosis. , 2022, European journal of cancer.

[6]  S. Ranque,et al.  Species Identification and In Vitro Antifungal Susceptibility of Paecilomyces/Purpureocillium Species Isolated from Clinical Respiratory Samples: A Multicenter Study , 2022, Journal of fungi.

[7]  R. Elhasid,et al.  Invasive Fusariosis in Pediatric Hematology/Oncology and Stem Cell Transplant Patients: A Report from the Israeli Society of Pediatric Hematology-Oncology , 2022, Journal of fungi.

[8]  OUP accepted manuscript , 2022, Clinical Infectious Diseases.

[9]  M. Ghannoum,et al.  GM-CSF: Orchestrating the Pulmonary Response to Infection , 2022, Frontiers in Pharmacology.

[10]  N. Wiederhold Emerging Fungal Infections: New Species, New Names, and Antifungal Resistance , 2021, Clinical chemistry.

[11]  D. Kontoyiannis,et al.  How different is invasive fusariosis in pediatric patients than in adults? A systematic review , 2021, Current opinion in infectious diseases.

[12]  A. Fuentefria,et al.  Diversity of Fusarium species causing invasive and disseminated infections. , 2021, Journal de mycologie medicale.

[13]  H. Badali,et al.  In vitro activity of olorofim against clinical isolates of the Fusarium oxysporum and Fusarium solani species complexes , 2021, Mycoses.

[14]  S. Lockhart,et al.  Molecular Techniques for Genus and Species Determination of Fungi From Fresh and Paraffin-Embedded Formalin-Fixed Tissue in the Revised EORTC/MSGERC Definitions of Invasive Fungal Infection. , 2021, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  A. Barać,et al.  Invasive infections with Purpureocillium lilacinum: clinical characteristics and outcome of 101 cases from FungiScope® and the literature , 2021, The Journal of antimicrobial chemotherapy.

[16]  P. Woo,et al.  Global guideline for the diagnosis and management of rare mould infections: an initiative of the European Confederation of Medical Mycology in cooperation with the International Society for Human and Animal Mycology and the American Society for Microbiology. , 2021, The Lancet. Infectious diseases.

[17]  Paige M. K. Larkin,et al.  Recognition of Diagnostic Gaps for Laboratory Diagnosis of Fungal Diseases: Expert Opinion from the Fungal Diagnostics Laboratories Consortium (FDLC) , 2021, Journal of clinical microbiology.

[18]  M. Hoenigl,et al.  Scedosporium and Lomentospora Infections: Contemporary Microbiological Tools for the Diagnosis of Invasive Disease , 2021, Journal of fungi.

[19]  E. Pérez-Nadales,et al.  Invasive Fusariosis in Nonneutropenic Patients, Spain, 2000–2015 , 2021, Emerging infectious diseases.

[20]  L. Moradi,et al.  Invasive Rasamsonia argillacea infection in chronic granulomatous disease: Report of a new case and literature review. , 2020, Journal de mycologie medicale.

[21]  D. Kontoyiannis,et al.  Role and Interpretation of Antifungal Susceptibility Testing for the Management of Invasive Fungal Infections , 2020, Journal of fungi.

[22]  L. Pagano,et al.  Do high MICs predict the outcome in invasive fusariosis? , 2020, The Journal of antimicrobial chemotherapy.

[23]  D. Seidel,et al.  Characterization and outcome of invasive infections due to Paecilomyces variotii: analysis of patients from the FungiScope® registry and literature reports , 2020, The Journal of antimicrobial chemotherapy.

[24]  Victor Pereira Rochetti,et al.  Peptidorhamnomannans From Scedosporium and Lomentospora Species Display Microbicidal Activity Against Bacteria Commonly Present in Cystic Fibrosis Patients , 2020, Frontiers in Cellular and Infection Microbiology.

[25]  F. Dromer,et al.  Scedosporiosis/lomentosporiosis observational study (SOS): Clinical significance of Scedosporium species identification. , 2020, Medical mycology.

[26]  B. Posteraro,et al.  Update on MALDI-TOF MS Identification of Filamentous Fungi. , 2020, Journal of clinical microbiology.

[27]  J. Guarro,et al.  Sarocladium and Acremonium infections: New faces of an old opportunistic fungus , 2020, Mycoses.

[28]  J. Buer,et al.  In vitro activity of olorofim (F901318) against fungi of the genus, Scedosporium and Rasamsonia as well as against Lomentospora prolificans, Exophiala dermatitidis and azole-resistant Aspergillus fumigatus. , 2020, International journal of antimicrobial agents.

[29]  M. Arendrup,et al.  In Vitro Activity of Manogepix (APX001A) and Comparators against Contemporary Molds: MEC Comparison and Preliminary Experience with Colorimetric MIC Determination , 2020, Antimicrobial Agents and Chemotherapy.

[30]  J. Frisvad,et al.  Classification of Aspergillus, Penicillium, Talaromyces and related genera (Eurotiales): An overview of families, genera, subgenera, sections, series and species , 2020, Studies in mycology.

[31]  M. Christner,et al.  Clinical characteristics and outcomes of invasive Lomentospora prolificans infections: Analysis of patients in the FungiScope® registry , 2020, Mycoses.

[32]  T. Walsh,et al.  Non-Aspergillus Hyaline Molds: Emerging Causes of Sino-Pulmonary Fungal Infections and Other Invasive Mycoses , 2020, Seminars in Respiratory and Critical Care Medicine.

[33]  M. Christner,et al.  Voriconazole plus terbinafine combination antifungal therapy for invasive Lomentospora prolificans infections: analysis of 41 patients from the FungiScope® registry 2008-2019. , 2020, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[34]  구자홍,et al.  Aspergillosis , 2020, Red Book Atlas of Pediatric Infectious Diseases.

[35]  P. Soler-Palacín,et al.  Invasive Scedosporium spp. and Lomentospora prolificans Infections in Pediatric Patients: Analysis of 55 Cases from FungiScope® and the Literature. , 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[36]  Yiyou Gu,et al.  Fosmanogepix (APX001) Is Effective in the Treatment of Immunocompromised Mice Infected with Invasive Pulmonary Scedosporiosis or Disseminated Fusariosis , 2019, Antimicrobial Agents and Chemotherapy.

[37]  J. Perfect,et al.  Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[38]  D. Seidel,et al.  Risk factors and mortality in invasive Rasamsonia spp. infection: Analysis of cases in the FungiScope® registry and from the literature , 2019, Mycoses.

[39]  C. Hennequin,et al.  In Vitro Susceptibility of Fusarium to Isavuconazole , 2019, Antimicrobial Agents and Chemotherapy.

[40]  D. Kontoyiannis,et al.  Therapeutic Challenges of Non-Aspergillus Invasive Mold Infections in Immunosuppressed Patients , 2019, Antimicrobial Agents and Chemotherapy.

[41]  M. Castanheira,et al.  In Vitro Activity of APX001A (Manogepix) and Comparator Agents against 1,706 Fungal Isolates Collected during an International Surveillance Program in 2017 , 2019, Antimicrobial Agents and Chemotherapy.

[42]  F. Marty,et al.  Outcomes of patients with invasive fusariosis who undergo further immunosuppressive treatments, is there a role for secondary prophylaxis? , 2019, Mycoses.

[43]  J. Guarro,et al.  Current knowledge on the etiology and epidemiology of Scopulariopsis infections. , 2019, Medical mycology.

[44]  T. Walsh,et al.  The expanding use of matrix-assisted laser desorption/ionization-time of flight mass spectroscopy in the diagnosis of patients with mycotic diseases , 2019, Expert review of molecular diagnostics.

[45]  D. Pakstis,et al.  Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope® , 2019, Critical reviews in microbiology.

[46]  F. Dalle,et al.  First case of proven invasive pulmonary infection due to Trichoderma longibrachiatum in a neutropenic patient with acute leukemia. , 2018, Journal de mycologie medicale.

[47]  J. Guarro,et al.  Lack of correlation of ECV and outcome in an in vivo murine model of systemic fusariosis. , 2018, Diagnostic microbiology and infectious disease.

[48]  D. Capone,et al.  Invasive mould disease in haematologic patients: comparison between fusariosis and aspergillosis. , 2018, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[49]  H. Matsuoka,et al.  Invasive Scopulariopsis alboflavescens infection in patient with acute myeloid leukemia , 2018, International Journal of Hematology.

[50]  Davise H. Larone,et al.  Larone’s Medically Important Fungi , 2018 .

[51]  T. Walsh,et al.  Recent Advances in the Treatment of Scedosporiosis and Fusariosis , 2018, Journal of fungi.

[52]  E. Cober,et al.  Fatal Fusarium infection manifesting as osteomyelitis following previous treatment with amphotericin B in a multi‐visceral transplant: Case report and review of Fusarium infections in solid organ transplantation , 2018, Transplant infectious disease : an official journal of the Transplantation Society.

[53]  M. Arendrup,et al.  EUCAST Determination of Olorofim (F901318) Susceptibility of Mold Species, Method Validation, and MICs , 2018, Antimicrobial Agents and Chemotherapy.

[54]  S. Ranque,et al.  Scedosporium and Lomentospora: an updated overview of underrated opportunists. , 2018, Medical mycology.

[55]  F. Cobo,et al.  Infections caused by Scedosporium/Lomentospora species: Clinical and microbiological findings in 21 cases , 2017, Medical mycology.

[56]  E. Stindel,et al.  Miltefosine-based regimen as salvage therapy in Lomentospora prolificans bone and joint infection. , 2017, Medecine et maladies infectieuses.

[57]  S. Ranque,et al.  Current antifungal treatment of fusariosis. , 2017, International journal of antimicrobial agents.

[58]  J. Cano-Lira,et al.  Ecology of Scedosporium Species: Present Knowledge and Future Research , 2018, Mycopathologia.

[59]  J. Jarvis,et al.  Modulating host immune responses to fight invasive fungal infections. , 2017, Current opinion in microbiology.

[60]  R. Guillemain,et al.  Clinical outcome of cystic fibrosis patients colonized by Scedosporium species following lung transplantation: A single‐center 15‐year experience , 2017, Transplant infectious disease : an official journal of the Transplantation Society.

[61]  D. Seidel,et al.  FungiScope™—Global Emerging Fungal Infection Registry , 2017, Mycoses.

[62]  J. Wingard,et al.  National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Immune Dysregulation and Pathobiology Working Group Report. , 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[63]  L. Blyn,et al.  Fatal disseminated Rasamsonia infection in cystic fibrosis post-lung transplantation. , 2017, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[64]  S. de Botton,et al.  Invasive cutaneous infection due to Scopulariopsis brevicaulis unsuccessfully treated with high-dose micafungin in a neutropenic patient , 2017, Infection.

[65]  T. Walsh,et al.  Scedosporiosis in a Combined Kidney and Liver Transplant Recipient: A Case Report of Possible Transmission from a Near-Drowning Donor , 2016, Case reports in transplantation.

[66]  B. Buchan,et al.  Treatment of Paecilomyces variotii pneumonia with posaconazole: case report and literature review , 2016, Mycoses.

[67]  S. Suerbaum,et al.  Fungal epidemiology and diversity in cystic fibrosis patients over a 5-year period in a national reference center. , 2016, Medical mycology.

[68]  A. Rodríguez-Tovar,et al.  Disseminated penicilliosis due to Penicillium chrysogenum in a pediatric patient with Henoch-Schönlein syndrome. , 2016, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[69]  J. Buer,et al.  In Vitro Activity of Isavuconazole against Rasamsonia Species , 2016, Antimicrobial Agents and Chemotherapy.

[70]  T. Walsh,et al.  PCR methodology and applications for the detection of human fungal pathogens , 2016, Expert review of molecular diagnostics.

[71]  J. Meis,et al.  Global molecular epidemiology and genetic diversity of Fusarium, a significant emerging group of human opportunists from 1958 to 2015 , 2016, Emerging microbes & infections.

[72]  M. Nucci,et al.  Fusariosis. , 2020, Seminars in respiratory and critical care medicine.

[73]  M. Ghannoum,et al.  International Evaluation of MIC Distributions and Epidemiological Cutoff Value (ECV) Definitions for Fusarium Species Identified by Molecular Methods for the CLSI Broth Microdilution Method , 2015, Antimicrobial Agents and Chemotherapy.

[74]  W. G. Nichols,et al.  Efficacy of transfusion with granulocytes from G-CSF/dexamethasone-treated donors in neutropenic patients with infection. , 2015, Blood.

[75]  Sameer S. Kadri,et al.  Role of granulocyte transfusions in invasive fusariosis: systematic review and single‐center experience , 2015, Transfusion.

[76]  T. Walsh,et al.  Importance of Fungal Histopathology in Immunocompromised Pediatric Patients: It's Not Just "Aspergillus" Anymore. , 2015, American journal of clinical pathology.

[77]  N. Lima,et al.  Molecular Biology of Food and Water Borne Mycotoxigenic and Mycotic Fungi , 2015 .

[78]  Z. Wan,et al.  In Vitro Triple Combination of Antifungal Drugs against Clinical Scopulariopsis and Microascus Species , 2015, Antimicrobial Agents and Chemotherapy.

[79]  M. Battegay,et al.  Multispecific Aspergillus T cells selected by CD137 or CD154 induce protective immune responses against the most relevant mold infections. , 2015, The Journal of infectious diseases.

[80]  A. Colombo,et al.  Risk factors for invasive fusariosis in patients with acute myeloid leukemia and in hematopoietic cell transplant recipients. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[81]  L. Fu,et al.  An outbreak of invasive fusariosis in a children's cancer hospital. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[82]  A. D. Diepeningen,et al.  Spectrum of Fusarium infections in tropical dermatology evidenced by multilocus sequencing typing diagnostics , 2015, Mycoses.

[83]  P. Reix,et al.  Impact of Scedosporium apiospermum complex seroprevalence in patients with cystic fibrosis. , 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[84]  D. Horn,et al.  Treatment and outcomes of invasive fusariosis: review of 65 cases from the PATH Alliance® registry , 2014, Mycoses.

[85]  Z. Gu,et al.  Quantitative multiplexed detection of common pulmonary fungal pathogens by labeled primer polymerase chain reaction. , 2014, Archives of pathology & laboratory medicine.

[86]  M. Boccadoro,et al.  Trichoderma species fungemia after high‐dose chemotherapy and autologous stem cell transplantation: a case report , 2014, Transplant Infectious Disease.

[87]  A. Rosengart,et al.  Mold infections of the central nervous system. , 2014, The New England journal of medicine.

[88]  B. Alexander,et al.  Complexities associated with the molecular and proteomic identification of Paecilomyces species in the clinical mycology laboratory. , 2014, Medical mycology.

[89]  E. Anaissie,et al.  Improvement in the outcome of invasive fusariosis in the last decade. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[90]  M. Caira,et al.  European Confederation of Medical Mycology (ECMM) epidemiological survey on invasive infections due to Fusarium species in Europe , 2014, European Journal of Clinical Microbiology & Infectious Diseases.

[91]  J. Guarro,et al.  Phylogeny of the Clinically Relevant Species of the Emerging Fungus Trichoderma and Their Antifungal Susceptibilities , 2014, Journal of Clinical Microbiology.

[92]  J. Guarro,et al.  In vitro antifungal susceptibility of clinical isolates of Arthrographis kalrae, a poorly known opportunistic fungus , 2014, Mycoses.

[93]  L. Pagano,et al.  ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[94]  A. Velegraki,et al.  Cluster of Fusarium verticillioides bloodstream infections among immunocompetent patients in an internal medicine department after reconstruction works in Larissa, Central Greece. , 2014, The Journal of hospital infection.

[95]  M. Netea,et al.  Interferon-gamma as adjunctive immunotherapy for invasive fungal infections: a case series , 2014, BMC Infectious Diseases.

[96]  A. Colombo,et al.  Earlier Diagnosis of Invasive Fusariosis with Aspergillus Serum Galactomannan Testing , 2014, PloS one.

[97]  T. Sorrell,et al.  In vitro activity of miltefosine as a single agent and in combination with voriconazole or posaconazole against uncommon filamentous fungal pathogens. , 2013, The Journal of antimicrobial chemotherapy.

[98]  Russell E. Lewis,et al.  Epidemiology and sites of involvement of invasive fungal infections in patients with haematological malignancies: a 20‐year autopsy study , 2013, Mycoses.

[99]  A. McLachlan,et al.  Terbinafine in Combination with Other Antifungal Agents for Treatment of Resistant or Refractory Mycoses: Investigating Optimal Dosing Regimens Using a Physiologically Based Pharmacokinetic Model , 2013, Antimicrobial Agents and Chemotherapy.

[100]  J. Guarro,et al.  Scopulariopsis, a Poorly Known Opportunistic Fungus: Spectrum of Species in Clinical Samples and In Vitro Responses to Antifungal Drugs , 2013, Journal of Clinical Microbiology.

[101]  M. Bougnoux,et al.  Rasamsonia argillacea species complex: taxonomy, pathogenesis and clinical relevance. , 2013, Future microbiology.

[102]  E. Roilides,et al.  Non‐Aspergillus fungal infections in chronic granulomatous disease , 2013, Mycoses.

[103]  L. Goldani,et al.  Paecilomyces variotii as an Emergent Pathogenic Agent of Pneumonia , 2013, Case reports in infectious diseases.

[104]  A. Velegraki,et al.  An unusual cluster of Acremonium kiliense fungaemias in a haematopoietic cell transplantation unit. , 2013, Diagnostic microbiology and infectious disease.

[105]  D. Ecker,et al.  PCR Followed by Electrospray Ionization Mass Spectrometry for Broad-Range Identification of Fungal Pathogens , 2013, Journal of Clinical Microbiology.

[106]  Steven M Holland,et al.  Invasive fungal infections in patients with chronic granulomatous disease. , 2013, Advances in experimental medicine and biology.

[107]  D. Siraj,et al.  Use of Voriconazole for the Treatment of Paecilomyces lilacinus Cutaneous Infections: Case Presentation and Review of Published Literature , 2013, Mycopathologia.

[108]  S. Holland,et al.  Invasive fungal infection in chronic granulomatous disease: insights into pathogenesis and management , 2012, Current opinion in infectious diseases.

[109]  J. Frisvad,et al.  Taxonomy and Antifungal Susceptibility of Clinically Important Rasamsonia Species , 2012, Journal of Clinical Microbiology.

[110]  Z. Gu,et al.  Evaluation of multiplexed PCR and liquid-phase array for identification of respiratory fungal pathogens. , 2012, Medical mycology.

[111]  P. Iwen,et al.  Invasive Scopulariopsis brevicaulis infection in an immunocompromised patient and review of prior cases caused by Scopulariopsis and Microascus species. , 2012, Medical mycology.

[112]  P. Hartemann,et al.  Fusarium species recovered from the water distribution system of a French university hospital. , 2012, International journal of hygiene and environmental health.

[113]  J. Meis,et al.  Species-Specific Antifungal Susceptibility Patterns of Scedosporium and Pseudallescheria Species , 2012, Antimicrobial Agents and Chemotherapy.

[114]  A. Fischer,et al.  Invasive mold infections in chronic granulomatous disease: a 25-year retrospective survey. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[115]  Ronald N. Jones,et al.  Activities of E1210 and Comparator Agents Tested by CLSI and EUCAST Broth Microdilution Methods against Fusarium and Scedosporium Species Identified Using Molecular Methods , 2011, Antimicrobial Agents and Chemotherapy.

[116]  J. Frisvad,et al.  Rasamsonia, a new genus comprising thermotolerant and thermophilic Talaromyces and Geosmithia species , 2011, Antonie van Leeuwenhoek.

[117]  I. Grigoriev,et al.  Trichoderma: the genomics of opportunistic success , 2011, Nature Reviews Microbiology.

[118]  G. Papanicolaou,et al.  Invasive Non-Aspergillus Mold Infections in Transplant Recipients, United States, 2001–2006 , 2011, Emerging infectious diseases.

[119]  T. Horii,et al.  In Vitro Activity of E1210, a Novel Antifungal, against Clinically Important Yeasts and Molds , 2011, Antimicrobial Agents and Chemotherapy.

[120]  J. Houbraken,et al.  Purpureocillium, a new genus for the medically important Paecilomyces lilacinus. , 2011, FEMS microbiology letters.

[121]  N. Young,et al.  Decreased infection-related mortality and improved survival in severe aplastic anemia in the past two decades. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[122]  S. Holland,et al.  Geosmithia argillacea: an emerging cause of invasive mycosis in human chronic granulomatous disease. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[123]  W. Meyer,et al.  Development and Validation of a Multiplex PCR for Detection of Scedosporium spp. in Respiratory Tract Specimens from Patients with Cystic Fibrosis , 2011, Journal of Clinical Microbiology.

[124]  O. Lortholary,et al.  Emergence of Disseminated Infections Due to Geosmithia argillacea in Patients with Chronic Granulomatous Disease Receiving Long-Term Azole Antifungal Prophylaxis , 2011, Journal of Clinical Microbiology.

[125]  E. Mylonakis,et al.  Fusarium Infection in Lung Transplant Patients: Report of 6 Cases and Review of the Literature , 2011, Medicine.

[126]  J. Latgé,et al.  Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity. , 2010, Blood.

[127]  J. Guarro,et al.  Spectrum of Clinically Relevant Acremonium Species in the United States , 2010, Journal of Clinical Microbiology.

[128]  M. Montagna,et al.  Chronic airway colonization by Scedosporium apiospermum with a fatal outcome in a patient with cystic fibrosis. , 2010, Medical mycology.

[129]  D. Geiser,et al.  Internet-Accessible DNA Sequence Database for Identifying Fusaria from Human and Animal Infections , 2010, Journal of Clinical Microbiology.

[130]  D. Kontoyiannis,et al.  Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009. , 2010, The Journal of infection.

[131]  J. Bouchara,et al.  Acremonium strictum Fungaemia in a Paediatric Immunocompromised Patient: Diagnosis and Treatment Difficulties , 2010, Mycopathologia.

[132]  N. Young,et al.  Granulocyte transfusions in severe aplastic anemia: an eleven-year experience , 2009, Haematologica.

[133]  O. Lee,et al.  Detection of Occult Scedosporium Species in Respiratory Tract Specimens from Patients with Cystic Fibrosis by Use of Selective Media , 2009, Journal of Clinical Microbiology.

[134]  P. Bordigoni,et al.  Disseminated Scopulariopsis brevicaulis infection in an allogeneic stem cell recipient: case report and review of the literature , 2009 .

[135]  T. Sorrell,et al.  Scedosporium prolificans osteomyelitis in an immunocompetent child treated with a novel agent, hexadecylphospocholine (miltefosine), in combination with terbinafine and voriconazole: a case report. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[136]  T. Mohammed,et al.  Pseudallescheria boydii (Scedosporium species) in 3 Lung Transplant Recipients: Computed Tomography Findings and Literature Review , 2009, Journal of computer assisted tomography.

[137]  E. Anaissie,et al.  Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[138]  T. Walsh,et al.  Host immune response against Scedosporium species. , 2009, Medical mycology.

[139]  L. Zhao,et al.  Toll-like receptor 4 polymorphisms and aspergillosis in stem-cell transplantation. , 2008, The New England journal of medicine.

[140]  R. D. Stulting,et al.  Fusarium keratitis and contact lens wear: facts and speculations. , 2008, Medical mycology.

[141]  J. Guarro,et al.  Central nervous system infections by members of the Pseudallescheria boydii species complex in healthy and immunocompromised hosts: epidemiology, clinical characteristics and outcome , 2008, Mycoses.

[142]  E. Mellado,et al.  Susceptibility Testing and Molecular Classification of Paecilomyces spp , 2008, Antimicrobial Agents and Chemotherapy.

[143]  J. Bruzzi,et al.  Imaging of pulmonary fusariosis in patients with hematologic malignancies. , 2008, AJR. American journal of roentgenology.

[144]  A. Baruchel,et al.  Invasive pulmonary infection due to Trichoderma longibrachiatum mimicking invasive Aspergillosis in a neutropenic patient successfully treated with voriconazole combined with caspofungin. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[145]  T. V. Van Schooneveld,et al.  Paecilomyces lilacinus infection in a liver transplant patient: case report and review of the literature , 2008, Transplant infectious disease : an official journal of the Transplantation Society.

[146]  T. Walsh,et al.  Amphotericin B formulations variably enhance antifungal activity of human neutrophils and monocytes against Fusarium solani: comparison with Aspergillus fumigatus. , 2008, The Journal of antimicrobial chemotherapy.

[147]  D. Ellis,et al.  Treatment of Scedosporiosis with Voriconazole: Clinical Experience with 107 Patients , 2008, Antimicrobial Agents and Chemotherapy.

[148]  Thomas J. Walsh,et al.  Infections Caused by Scedosporium spp , 2008, Clinical Microbiology Reviews.

[149]  B. Esmaeli,et al.  Fungal endophthalmitis in a tertiary care cancer center: a review of 23 cases , 2008, European Journal of Clinical Microbiology & Infectious Diseases.

[150]  L. Griškevičius,et al.  Nonfatal Trichoderma citrinoviride pneumonia in an acute myeloid leukemia patient , 2008, Annals of Hematology.

[151]  S. Burdach,et al.  Lethal double infection with Acremonium strictum and Aspergillus fumigatus during induction chemotherapy in a child with ALL , 2007, Pediatric blood & cancer.

[152]  T. Walsh,et al.  Cross-reactivity of non-Aspergillus fungal species in the Aspergillus galactomannan enzyme immunoassay. , 2007, Diagnostic microbiology and infectious disease.

[153]  T. Walsh,et al.  Fungal infections in primary immunodeficiencies , 2007, European Journal of Pediatrics.

[154]  D. Paterson,et al.  Scedosporium prolificans brain abscess in a patient with chronic granulomatous disease: Successful combination therapy with voriconazole and terbinafine , 2007, Scandinavian journal of infectious diseases.

[155]  N. Okhravi,et al.  Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections. , 2006, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[156]  D. Kleiner,et al.  Host-dependent patterns of tissue injury in invasive pulmonary aspergillosis. , 2005, American journal of clinical pathology.

[157]  Russell E. Lewis,et al.  Scedosporium infection in a tertiary care cancer center: a review of 25 cases from 1989-2006. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[158]  R. Yamazaki,et al.  Systemic infection due to Acremonium after allogeneic peripheral blood stem cell transplantation. , 2006, Internal medicine.

[159]  K. Wannemuehler,et al.  Multistate outbreak of Fusarium keratitis associated with use of a contact lens solution. , 2006, JAMA.

[160]  T. Wong,et al.  An outbreak of Fusarium keratitis associated with contact lens wear in Singapore. , 2006, JAMA.

[161]  M. J. Buitrago,et al.  In Vitro Activities of 10 Combinations of Antifungal Agents against the Multiresistant Pathogen Scopulariopsis brevicaulis , 2006, Antimicrobial Agents and Chemotherapy.

[162]  J. Graybill,et al.  Posaconazole as salvage treatment for invasive fusariosis in patients with underlying hematologic malignancy and other conditions. , 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[163]  M. J. Buitrago,et al.  Head-to-Head Comparison of the Activities of Currently Available Antifungal Agents against 3,378 Spanish Clinical Isolates of Yeasts and Filamentous Fungi , 2006, Antimicrobial Agents and Chemotherapy.

[164]  S. Holland,et al.  Effect of Amphotericin B and Micafungin Combination on Survival, Histopathology, and Fungal Burden in Experimental Aspergillosis in the p47phox−/− Mouse Model of Chronic Granulomatous Disease , 2006, Antimicrobial Agents and Chemotherapy.

[165]  S. Burdette,et al.  Intestinal invasion and disseminated disease associated with Penicillium chrysogenum , 2005, Annals of Clinical Microbiology and Antimicrobials.

[166]  C. Burgaleta,et al.  Nonfatal pulmonary Trichoderma viride infection in an adult patient with acute myeloid leukemia: report of one case and review of the literature. , 2005, Diagnostic microbiology and infectious disease.

[167]  E. Bash,et al.  Fatal necrotizing esophagitis due toPenicillium chrysogenum in a patient with acquired immunodeficiency syndrome , 1992, European Journal of Clinical Microbiology and Infectious Diseases.

[168]  T. Walsh,et al.  Control, immunoregulation, and expression of innate pulmonary host defenses against Aspergillus fumigatus. , 2005, Medical mycology.

[169]  Nina Singh,et al.  Infections due to Scedosporium apiospermum and Scedosporium prolificans in transplant recipients: clinical characteristics and impact of antifungal agent therapy on outcome. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[170]  R. Herbrecht,et al.  Successful treatment of Fusarium proliferatum pneumonia with posaconazole in a lung transplant recipient. , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[171]  J. Robinson,et al.  Genetic Diversity of Human Pathogenic Members of the Fusarium oxysporum Complex Inferred from Multilocus DNA Sequence Data and Amplified Fragment Length Polymorphism Analyses: Evidence for the Recent Dispersion of a Geographically Widespread Clonal Lineage and Nosocomial Origin , 2004, Journal of Clinical Microbiology.

[172]  T. Walsh,et al.  Interferon-gamma and colony-stimulating factors as adjuvant therapy for refractory fungal infections in children. , 2004, The Pediatric infectious disease journal.

[173]  E. Anaissie,et al.  Fusarium infection in hematopoietic stem cell transplant recipients. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[174]  J. Peter,et al.  Efficacy, Safety, and Plasma Pharmacokinetics of Escalating Dosages of Intravenously Administered Ravuconazole Lysine Phosphoester for Treatment of Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits , 2004, Antimicrobial Agents and Chemotherapy.

[175]  D. Kontoyiannis,et al.  The significance of isolation of saprophytic molds from the lower respiratory tract in patients with cancer , 2004, Cancer.

[176]  T J Walsh,et al.  Infections due to emerging and uncommon medically important fungal pathogens. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[177]  J. Perfect,et al.  Fatal Scopulariopsis brevicaulis infection in a paediatric stem-cell transplant patient treated with voriconazole and caspofungin and a review of Scopulariopsis infections in immunocompromised patients. , 2004, The Journal of infection.

[178]  C. Viscoli,et al.  Successful treatment of Acremonium fungemia with voriconazole , 2003, Mycoses.

[179]  D. Kontoyiannis,et al.  Glucocorticoids and invasive fungal infections , 2003, The Lancet.

[180]  M. Pfaller,et al.  Activities of Caspofungin, Itraconazole, Posaconazole, Ravuconazole, Voriconazole, and Amphotericin B against 448 Recent Clinical Isolates of Filamentous Fungi , 2003, Journal of Clinical Microbiology.

[181]  E. Anaissie,et al.  Outcome predictors of 84 patients with hematologic malignancies and Fusarium infection , 2003, Cancer.

[182]  J. Perfect,et al.  Voriconazole treatment for less-common, emerging, or refractory fungal infections. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[183]  D. Leehey,et al.  Paecilomyces peritonitis: case report and review of the literature. , 2003, Clinical nephrology.

[184]  John H Rex,et al.  Pathogenic molds (including Aspergillus species) in hospital water distribution systems: a 3-year prospective study and clinical implications for patients with hematologic malignancies. , 2003, Blood.

[185]  Paul E. Verweij,et al.  In Vitro Drug Interaction Modeling of Combinations of Azoles with Terbinafine against Clinical Scedosporium prolificans Isolates , 2003, Antimicrobial Agents and Chemotherapy.

[186]  L. Lachaud,et al.  Invasive infections due to Trichoderma species: report of 2 cases, findings of in vitro susceptibility testing, and review of the literature. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[187]  R. Herbrecht,et al.  Acremonium strictum Pulmonary Infection in a Leukemic Patient Successfully Treated with Posaconazole After Failure of Amphotericin B , 2002, European Journal of Clinical Microbiology and Infectious Diseases.

[188]  E. Anaissie,et al.  Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[189]  D. Denning,et al.  Invasive infection due to penicillium species other than P. marneffei. , 2002, The Journal of infection.

[190]  M. Gompels,et al.  Scedosporium apiospermum in chronic granulomatous disease treated with an HLA matched bone marrow transplant , 2002, Journal of clinical pathology.

[191]  J. Fung,et al.  Pseudallescheria boydii (Anamorph Scedosporium apiospermum) Infection in Solid Organ Transplant Recipients in a Tertiary Medical Center and Review of the Literature , 2002, Medicine.

[192]  M. Albitar,et al.  Epidemiology, Molecular Mycology, and Environmental Sources of Fusarium Infection in Patients with Cancer , 2002, Infection Control & Hospital Epidemiology.

[193]  T. Walsh,et al.  Antifungal Triazoles and Polymorphonuclear Leukocytes Synergize To Cause Increased Hyphal Damage to Scedosporium prolificans and Scedosporium apiospermum , 2002, Antimicrobial Agents and Chemotherapy.

[194]  T. Walsh,et al.  Synergy, Pharmacodynamics, and Time-Sequenced Ultrastructural Changes of the Interaction between Nikkomycin Z and the Echinocandin FK463 against Aspergillus fumigatus , 2001, Antimicrobial Agents and Chemotherapy.

[195]  S. Chanock,et al.  Fusariosis associated with pathogenic fusarium species colonization of a hospital water system: a new paradigm for the epidemiology of opportunistic mold infections. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[196]  Alice N. Neely,et al.  Survival of Some Medically Important Fungi on Hospital Fabrics and Plastics , 2001, Journal of Clinical Microbiology.

[197]  J. Rodríguez-Tudela,et al.  Airborne outbreak of nosocomial Scedosporium prolificans infection , 2001, The Lancet.

[198]  C. Payá,et al.  Fusarium infection after solid-organ transplantation. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[199]  M. Jacobson,et al.  Invasive Fungal Sinusitis and Meningitis Due toArthrographis kalrae in a Patient with AIDS , 2001, Journal of Clinical Microbiology.

[200]  J. Guarro,et al.  Mixed Infection Caused by Two Species ofFusarium in a Human Immunodeficiency Virus-Positive Patient , 2000, Journal of Clinical Microbiology.

[201]  J. Bouchara,et al.  Clinical Significance of Scedosporium apiospermum in Patients with Cystic Fibrosis , 2000, European Journal of Clinical Microbiology and Infectious Diseases.

[202]  J. Montoya,et al.  Invasive fungal sinusitis due to Scedosporium apiospermum in a patient with AIDS. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[203]  W. Liles,et al.  Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens. , 1999, The Journal of infectious diseases.

[204]  C. Thio,et al.  Paecilomyces lilacinus fungemia in an adult bone marrow transplant recipient. , 1999, Medical mycology.

[205]  A. Fischer,et al.  Invasive pulmonary infection due to Scedosporium apiospermum in two children with chronic granulomatous disease. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[206]  P. H. Itina,et al.  Cutaneous manifestations of Paecilomyces lilacinus infection induced by a contaminated skin lotion in patients who are severely immunosuppressed , 1998 .

[207]  J. Rich,et al.  Pulmonary aspergillosis and invasive disease in AIDS: review of 342 cases. , 1998, Chest.

[208]  Johnson M Liu,et al.  Invasive Infection with Fusarium chlamydosporum in a Patient with Aplastic Anemia , 1998, Journal of Clinical Microbiology.

[209]  J. Perfect,et al.  Morphologic criteria for the preliminary identification of Fusarium, Paecilomyces, and Acremonium species by histopathology. , 1998, American journal of clinical pathology.

[210]  J. Guarro,et al.  Acremonium species: new emerging fungal opportunists--in vitro antifungal susceptibilities and review. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[211]  E. Anaissie,et al.  Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management. , 1997, Blood.

[212]  N. Giri,et al.  Invasive aspergillosis in human immunodeficiency virus-infected children. , 1997, The Pediatric infectious disease journal.

[213]  S. Rossmann,et al.  Trichoderma longibrachiatum infection in a pediatric patient with aplastic anemia , 1997, Journal of clinical microbiology.

[214]  P. Itin,et al.  Outbreak of Invasive Mycoses Caused by Paecilomyces lilacinus from a Contaminated Skin Lotion , 1996, Annals of Internal Medicine.

[215]  J. Perfect,et al.  Fatal, disseminated Acremonium strictum infection in a neutropenic host , 1996, Journal of clinical microbiology.

[216]  J. Martínez-Suárez,et al.  Nosocomial outbreak caused by Scedosporium prolificans (inflatum): four fatal cases in leukemic patients , 1995, Journal of clinical microbiology.

[217]  E. Roilides,et al.  Acremonium fungemia in two immunocompromised children. , 1995, The Pediatric infectious disease journal.

[218]  E. Anaissie,et al.  Taxonomy, biology, and clinical aspects of Fusarium species , 1994, Clinical Microbiology Reviews.

[219]  D. Venzon,et al.  Antifungal activity of elutriated human monocytes against Aspergillus fumigatus hyphae: enhancement by granulocyte-macrophage colony-stimulating factor and interferon-gamma. , 1994, The Journal of infectious diseases.

[220]  B. Kjos,et al.  Brain abscess following marrow transplantation: experience at the Fred Hutchinson Cancer Research Center, 1984-1992. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[221]  N. M. Brown,et al.  Acremonium infection in a neutropenic patient. , 1992, The Journal of infection.

[222]  J. Levine,et al.  Scopulariopsis Peritonitis in a Patient Undergoing Continuous Ambulatory Peritoneal Dialysis , 1992, Peritoneal Dialysis International.

[223]  G. Phillips,et al.  Invasive hyalohyphomycosis caused by Scopulariopsis brevicaulis in a patient undergoing allogeneic bone marrow transplant. , 1989, Diagnostic microbiology and infectious disease.

[224]  J. Karp,et al.  Diagnosis and successful treatment of fusariosis in the compromised host. , 1988, The Journal of infectious diseases.

[225]  J. Neglia,et al.  Invasive Scopulariopsis in the immunocompromised host. , 1987, The American journal of medicine.

[226]  R. Foos,et al.  Fungal endophthalmitis following intraocular lens implantation. A surgical epidemic. , 1980, Archives of ophthalmology.